Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
Open Access
- 3 March 2011
- journal article
- Published by Journal of Molecular Signaling in Journal of Molecular Signaling
- Vol. 6 (1) , 2
Abstract
The K-RAS oncogene is widely mutated in human cancers. Activating mutations in K-RAS give rise to constitutive signalling through the MAPK/ERK and PI3K/AKT pathways promoting increased cell division, reduced apoptosis and transformation. The majority of activating mutations in K-RAS are located in codons 12 and 13. In a human colorectal cancer we identified a novel K-RAS co-mutation that altered codons 19 and 20 resulting in transitions at both codons (L19F/T20A) in the same allele. Using focus forming transformation assays in vitro , we showed that co-mutation of L19F/T20A in K-RAS demonstrated intermediate transforming ability that was greater than that of individual L19F and T20A mutants, but less than that of G12D and G12V K-RAS mutants. This demonstrated the synergistic effects of co-mutation of codons 19 and 20 and illustrated that co-mutation of these codons is functionally significant.Keywords
This publication has 24 references indexed in Scilit:
- Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk studyBMC Cancer, 2010
- Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicineBritish Journal of Cancer, 2010
- K‐ras exon 4A has a tumour suppressor effect on carcinogen‐induced murine colonic adenoma formationThe Journal of Pathology, 2009
- Mutated K‐rasAsp12 promotes tumourigenesis in ApcMin mice more in the large than the small intestines, with synergistic effects between K‐ras and Wnt pathwaysInternational Journal of Experimental Pathology, 2009
- High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal CancerAmerican Journal of Clinical Pathology, 2008
- Characterization of a novel oncogenic K-ras mutation in colon cancerBiochemical and Biophysical Research Communications, 2007
- Distinctive clinicopathological features ofKi-ras mutated colorectal cancersJournal of Surgical Oncology, 2006
- Impact ofGSTT1, GSTM1, GSTP1andNAT2genotypes onKRAS2andTP53gene mutations in colorectal cancerInternational Journal of Cancer, 2004
- High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patientsInternational Journal of Cancer, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003